BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12573176)

  • 1. Does tobacco industry marketing of 'light' cigarettes give smokers a rationale for postponing quitting?
    Gilpin EA; Emery S; White MM; Pierce JP
    Nicotine Tob Res; 2002; 4 Suppl 2():S147-55. PubMed ID: 12573176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescents' beliefs about the risks involved in smoking "light" cigarettes.
    Kropp RY; Halpern-Felsher BL
    Pediatrics; 2004 Oct; 114(4):e445-51. PubMed ID: 15466070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cessation among smokers of "light" cigarettes: results from the 2000 national health interview survey.
    Tindle HA; Rigotti NA; Davis RB; Barbeau EM; Kawachi I; Shiffman S
    Am J Public Health; 2006 Aug; 96(8):1498-504. PubMed ID: 16809583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stages of change and other factors in 'light' cigarette smokers.
    Kelbsch J; Meyer C; Rumpf HJ; John U; Hapke U
    Eur J Public Health; 2005 Apr; 15(2):146-51. PubMed ID: 15941759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does perceived safety of light cigarette encourage smokers to smoke more or to inhale more deeply?
    Lee JM; Chen SH; Hsieh CJ
    Int J Public Health; 2008; 53(5):236-44. PubMed ID: 18821055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lightest market in the world: light and mild cigarettes in Japan.
    Assunta M; Chapman S
    Nicotine Tob Res; 2008 May; 10(5):803-10. PubMed ID: 18569753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications.
    Pederson LL; Nelson DE
    Nicotine Tob Res; 2007 May; 9(5):525-34. PubMed ID: 17454709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between newspaper coverage of 'light' cigarette litigation and beliefs about 'lights' among American adolescents and young adults: the impact on risk perceptions and quitting intentions.
    Dunlop SM; Romer D
    Tob Control; 2010 Aug; 19(4):267-73. PubMed ID: 20530139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smokers' interest in using nicotine replacement to aid smoking reduction.
    Shiffman S; Hughes JR; Ferguson SG; Pillitteri JL; Gitchell JG; Burton SL
    Nicotine Tob Res; 2007 Nov; 9(11):1177-82. PubMed ID: 17978992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of selectors of nicotine replacement therapy.
    Shiffman S; Di Marino ME; Sweeney CT
    Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes.
    Bernert JT; Jain RB; Pirkle JL; Wang L; Miller BB; Sampson EJ
    Nicotine Tob Res; 2005 Oct; 7(5):729-38. PubMed ID: 16191744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' views on smoking cessation and tobacco harm reduction during drug treatment.
    Richter KP; McCool RM; Okuyemi KS; Mayo MS; Ahluwalia JS
    Nicotine Tob Res; 2002; 4 Suppl 2():S175-82. PubMed ID: 12573178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette.
    Benowitz NL; Hall SM; Stewart S; Wilson M; Dempsey D; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2479-85. PubMed ID: 18006940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower nicotine cigarettes may not lower harm.
    Strasser AA; Lerman C; Cappella JN
    LDI Issue Brief; 2006; 12(2):1-4. PubMed ID: 17302017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ever users versus never users of a "less risky" cigarette.
    Hughes JR; Keely JP; Callas PW
    Psychol Addict Behav; 2005 Dec; 19(4):439-42. PubMed ID: 16366816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco industry marketing, population-based tobacco control, and smoking behavior.
    Pierce JP
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S327-34. PubMed ID: 18021907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.